These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
236 related articles for article (PubMed ID: 32592583)
1. Clinical trial of proton craniospinal irradiation for leptomeningeal metastases. Yang TJ; Wijetunga NA; Yamada J; Wolden S; Mehallow M; Goldman DA; Zhang Z; Young RJ; Kris MG; Yu HA; Seidman AD; Gavrilovic IT; Lin A; Santomasso B; Grommes C; Piotrowski AF; Schaff L; Stone JB; DeAngelis LM; Boire A; Pentsova E Neuro Oncol; 2021 Jan; 23(1):134-143. PubMed ID: 32592583 [TBL] [Abstract][Full Text] [Related]
2. Randomized Phase II Trial of Proton Craniospinal Irradiation Versus Photon Involved-Field Radiotherapy for Patients With Solid Tumor Leptomeningeal Metastasis. Yang JT; Wijetunga NA; Pentsova E; Wolden S; Young RJ; Correa D; Zhang Z; Zheng J; Steckler A; Bucwinska W; Bernstein A; Betof Warner A; Yu H; Kris MG; Seidman AD; Wilcox JA; Malani R; Lin A; DeAngelis LM; Lee NY; Powell SN; Boire A J Clin Oncol; 2022 Nov; 40(33):3858-3867. PubMed ID: 35802849 [TBL] [Abstract][Full Text] [Related]
3. Craniospinal irradiation prior to stem cell transplant for hematologic malignancies with CNS involvement: Effectiveness and toxicity after photon or proton treatment. Gunther JR; Rahman AR; Dong W; Yehia ZA; Kebriaei P; Rondon G; Pinnix CC; Milgrom SA; Allen PK; Dabaja BS; Smith GL Pract Radiat Oncol; 2017; 7(6):e401-e408. PubMed ID: 28666906 [TBL] [Abstract][Full Text] [Related]
4. Proton therapy for adult medulloblastoma: Acute toxicity and disease control outcomes. Liu IC; Holtzman AL; Rotondo RL; Indelicato DJ; Gururangan S; Cavaliere R; Carter B; Morris CG; Tavanaiepour D; Rutenberg MS J Neurooncol; 2021 Jul; 153(3):467-476. PubMed ID: 34105033 [TBL] [Abstract][Full Text] [Related]
5. The comparison of acute toxicities associated with craniospinal irradiation between photon beam therapy and proton beam therapy in children with brain tumors. Uemura S; Demizu Y; Hasegawa D; Fujikawa T; Inoue S; Nishimura A; Tojyo R; Nakamura S; Kozaki A; Saito A; Kishimoto K; Ishida T; Mori T; Koyama J; Kawamura A; Akasaka Y; Yoshida M; Fukumitsu N; Soejima T; Kosaka Y Cancer Med; 2022 Mar; 11(6):1502-1510. PubMed ID: 35137555 [TBL] [Abstract][Full Text] [Related]
6. A systematic review of craniospinal irradiation for leptomeningeal disease: past, present, and future. Maillie L; Salgado LR; Lazarev S Clin Transl Oncol; 2021 Oct; 23(10):2109-2119. PubMed ID: 33881707 [TBL] [Abstract][Full Text] [Related]
7. Craniospinal irradiation for leptomeningeal metastasis of solid tumors: survival analysis and prognostic factors. Takeda K; Umezawa R; Yamamoto T; Takahashi N; Jingu K J Radiat Res; 2024 Sep; 65(5):667-675. PubMed ID: 39154378 [TBL] [Abstract][Full Text] [Related]
8. Craniospinal irradiation for CNS leukemia: rates of response and durability of CNS control. Ebadi M; Morse M; Gooley T; Ermoian R; Halasz LM; Lo SS; Yang JT; Blau MH; Percival ME; Cassaday RD; Graber J; Taylor LP; Venur V; Tseng YD J Neurooncol; 2024 Jan; 166(2):351-357. PubMed ID: 38244173 [TBL] [Abstract][Full Text] [Related]
9. Volumetric de-escalation and improved acute toxicity with proton craniospinal irradiation using a vertebral body-sparing technique. Chou B; Hopper A; Elster J; Crawford JR; McConnell K; Chang A; Mundt AJ; MacEwan I Pediatr Blood Cancer; 2022 May; 69(5):e29489. PubMed ID: 34866330 [TBL] [Abstract][Full Text] [Related]
10. Technique, outcomes, and acute toxicities in adults treated with proton beam craniospinal irradiation. Barney CL; Brown AP; Grosshans DR; McAleer MF; de Groot JF; Puduvalli V; Tucker SL; Crawford CN; Gilbert MR; Brown PD; Mahajan A Neuro Oncol; 2014 Jan; 16(2):303-9. PubMed ID: 24311638 [TBL] [Abstract][Full Text] [Related]
11. Craniospinal irradiation(CSI) in patients with leptomeningeal metastases: risk-benefit-profile and development of a prognostic score for decision making in the palliative setting. Devecka M; Duma MN; Wilkens JJ; Kampfer S; Borm KJ; Münch S; Straube C; Combs SE BMC Cancer; 2020 Jun; 20(1):501. PubMed ID: 32487151 [TBL] [Abstract][Full Text] [Related]
12. Early outcome after craniospinal irradiation with pencil beam scanning proton therapy for children, adolescents and young adults with brain tumors. Vázquez M; Bachmann N; Pica A; Bolsi A; De Angelis C; Lomax AJ; Weber DC Pediatr Blood Cancer; 2023 Feb; 70(2):e30087. PubMed ID: 36377685 [TBL] [Abstract][Full Text] [Related]
13. A Multi-institutional Comparative Analysis of Proton and Photon Therapy-Induced Hematologic Toxicity in Patients With Medulloblastoma. Liu KX; Ioakeim-Ioannidou M; Susko MS; Rao AD; Yeap BY; Snijders AM; Ladra MM; Vogel J; Zaslowe-Dude C; Marcus KJ; Yock TI; Grassberger C; Braunstein SE; Haas-Kogan DA; Terezakis SA; MacDonald SM Int J Radiat Oncol Biol Phys; 2021 Mar; 109(3):726-735. PubMed ID: 33243479 [TBL] [Abstract][Full Text] [Related]
14. Dynamic Mutational Landscape of Cerebrospinal Fluid Circulating Tumor DNA and Predictors of Survival after Proton Craniospinal Irradiation for Leptomeningeal Metastases. Wijetunga NA; Goglia AG; Weinhold N; Berger MF; Cislo M; Higginson DS; Chabot K; Osman AM; Schaff L; Pentsova E; Miller AM; Powell SN; Boire A; Yang JT Clin Cancer Res; 2023 Feb; 29(4):775-783. PubMed ID: 36449664 [TBL] [Abstract][Full Text] [Related]
15. Overall survival and secondary malignant neoplasms in children receiving passively scattered proton or photon craniospinal irradiation for medulloblastoma. Paulino AC; Ludmir EB; Grosshans DR; Su JM; McGovern SL; Okcu MF; McAleer MF; Baxter PA; Mahajan A; Chintagumpala MM Cancer; 2021 Oct; 127(20):3865-3871. PubMed ID: 34254296 [TBL] [Abstract][Full Text] [Related]
16. Late toxicity following craniospinal radiation for early-stage medulloblastoma. Christopherson KM; Rotondo RL; Bradley JA; Pincus DW; Wynn TT; Fort JA; Morris CG; Mendenhall NP; Marcus RB; Indelicato DJ Acta Oncol; 2014 Apr; 53(4):471-80. PubMed ID: 24564687 [TBL] [Abstract][Full Text] [Related]
17. Outcome and prognostic factors following palliative craniospinal irradiation for leptomeningeal carcinomatosis. El Shafie RA; Böhm K; Weber D; Lang K; Schlaich F; Adeberg S; Paul A; Haefner MF; Katayama S; Sterzing F; Hörner-Rieber J; Löw S; Herfarth K; Debus J; Rieken S; Bernhardt D Cancer Manag Res; 2019; 11():789-801. PubMed ID: 30697071 [TBL] [Abstract][Full Text] [Related]
18. Quantitative cerebrospinal fluid circulating tumor cells are a potential biomarker of response for proton craniospinal irradiation for leptomeningeal metastasis. Wijetunga NA; Boire A; Young RJ; Yamada Y; Wolden S; Yu H; Kris M; Seidman A; Betof-Warner A; Diaz M; Reiner A; Malani R; Pentsova E; Yang JT Neurooncol Adv; 2021; 3(1):vdab181. PubMed ID: 34993483 [TBL] [Abstract][Full Text] [Related]
19. Craniospinal irradiation with concomitant and adjuvant temozolomide--a feasibility assessment of toxicity in patients with glioblastoma with a PNET component. O'Leary B; Mandeville HC; Fersht N; Solda F; Mycroft J; Zacharoulis S; Vaidya S; Saran F J Neurooncol; 2016 Apr; 127(2):295-302. PubMed ID: 26842817 [TBL] [Abstract][Full Text] [Related]
20. Phantosmia during proton radiation and differences in frequency of phantosmia rates based on proton craniospinal irradiation technique for pediatric brain tumor patients. Ioakeim-Ioannidou M; Daartz J; Erfani P; Urell T; Lalonde A; Berv J; Leahy S; Fullerton B; Bolton R; Yock T; Tarbell N; Yeap B; MacDonald SM Pediatr Blood Cancer; 2024 May; 71(5):e30927. PubMed ID: 38421306 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]